Non-Muscle-Invasive Conditions: Enhancing Treatment and Surveillance Strategies
Received Date: Jan 01, 2025 / Published Date: Jan 31, 2025
Abstract
Non-muscle-invasive bladder cancer (NMIBC) accounts for the majority of bladder cancer cases and is characterized by a high recurrence rate, necessitating rigorous treatment and surveillance strategies. Optimal management involves transurethral resection of the bladder tumor (TURBT), often followed by intravesical therapy with Bacillus Calmette- Guérin (BCG) or chemotherapy to reduce recurrence and progression risks. Risk stratification plays a crucial role in guiding treatment decisions, balancing efficacy with minimizing adverse effects. Surveillance strategies, including cystoscopy and urinary biomarkers, are essential for early recurrence detection. Despite advancements, challenges such as BCG shortages, treatment resistance, and patient compliance remain. This review explores current therapeutic approaches, surveillance methodologies, and emerging strategies to enhance NMIBC management.
Citation: Aswan P (2025) Non-Muscle-Invasive Conditions: Enhancing Treatment and Surveillance Strategies. J Orthop Oncol 11: 308. Doi: 10.4172/2472-016X.1000308
Copyright: 漏 2025 Aswan P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open 91桃色 Journals
Article Tools
Article Usage
- Total views: 376
- [From(publication date): 0-0 - Jul 25, 2025]
- Breakdown by view type
- HTML page views: 303
- PDF downloads: 73
